Hemagglutinin pseudotyped lentiviral particles: Characterization of a new method for avian H5N1 influenza sero-diagnosis

被引:68
作者
Nefkens, Isabelle
Garcia, Jean-Michel
Ling, Chu Shui
Lagarde, Nadege
Nicholls, John
Tang, Dong Jiang
Peiris, Malik
Buchy, Philippe
Altmeyer, Ralf
机构
[1] HKU, Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[3] Inst Pasteur Cambodia, Phnom Penh, Cambodia
[4] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
influenza; pseudotyped lentiviral particles; H5N1; serodiagnostic;
D O I
10.1016/j.jcv.2007.02.005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Highly pathogenic avian influenza (HPAI) H5N1 has spread globally in birds and infected over 270 humans with an apparently high mortality rate. Serologic studies to determine the extent of asymptomatic H5N1 infection in humans and other mammals and to investigate the immunogenicity of current H5N1 vaccine candidates have been hampered by the biosafety requirements needed for H5N1 microneutralization tests. Objective: Development of a serodiagnostic tool for highly pathogenic influenza that reproduces H5N1 biology but can be used with less biohazard. Study Design: We have generated and evaluated H5 hemagglutinin pseudotyped lentiviral particles encoding the luciferase reporter (H5pp). Results: H5pp entry into target cells depends on alpha 2-3 cell surface sialic acids and requires low pH for membrane fusion. H5pp infectivity is specifically neutralized by sera from patients and animals infected with H5N1 and correlates well with conventional microneutralization test. Conclusions: H5pp reproduce H5N1 influenza virus entry into target cells and potentially provides a high-throughput and safe method for sero-epidemiology. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 26 条
  • [11] C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles
    Lozach, PY
    Amara, A
    Bartosch, B
    Virelizier, JL
    Arenzana-Seisdedos, F
    Cosset, FL
    Altmeyer, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) : 32035 - 32045
  • [12] INFECTIOUS ENTRY PATHWAY OF INFLUENZA-VIRUS IN A CANINE KIDNEY-CELL LINE
    MATLIN, KS
    REGGIO, H
    HELENIUS, A
    SIMONS, K
    [J]. JOURNAL OF CELL BIOLOGY, 1981, 91 (03) : 601 - 613
  • [13] A primate model to study the pathogenesis of influenza A (H5N1) virus infection
    Rimmelzwaan, GF
    Kuiken, T
    van Amerongen, G
    Bestebroer, TM
    Fouchier, RAM
    Osterhaus, ADME
    [J]. AVIAN DISEASES, 2003, 47 : 931 - 933
  • [14] Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays
    Rowe, T
    Abernathy, RA
    Hu-Primmer, J
    Thompson, WW
    Lu, XH
    Lim, W
    Fukuda, K
    Cox, NJ
    Katz, JM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) : 937 - 943
  • [15] Avian and human receptor binding by hemagglutinins of influenza A viruses
    Russell, RJ
    Stevens, DJ
    Haire, LF
    Gamblin, SJ
    Skehel, JJ
    [J]. GLYCOCONJUGATE JOURNAL, 2006, 23 (1-2) : 85 - 92
  • [16] Mink lung epithelial cells: Unique cell line that supports influenza A and B virus replication
    Schultz-Cherry, S
    Dybdahl-Sissoko, N
    McGregor, M
    Hinshaw, VS
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (12) : 3718 - 3720
  • [17] Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
    Simmons, G
    Reeves, JD
    Rennekamp, AJ
    Amberg, SM
    Piefer, AJ
    Bates, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (12) : 4240 - 4245
  • [18] Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin
    Skehel, JJ
    Wiley, DC
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2000, 69 : 531 - 569
  • [19] SKEHEL JJ, 1983, B WORLD HEALTH ORGAN, V61, P671
  • [20] Influenza haemagglutinin
    Skehel, JJ
    Wiley, DC
    [J]. VACCINE, 2002, 20 : S51 - S54